18.60
price down icon1.74%   -0.33
 
loading

Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
14.08%
4.684
4.106 5.086 5.774 3.613
Operating Income/Loss
14.97%
-7.197
-6.26 -7.617 -7.794 -6.595
Net Income/Loss
16.03%
-7.02
-6.05 -7.314 -7.462 -6.334
Basic Average Shares
0.26%
23.48
23.41 0.4615 22.72 21.37
Diluted Average Shares
0.26%
23.48
23.41 0.4615 22.72 21.37
Basic Earnings Per Share
15.38%
-0.30
-0.26 -0.31 -0.44 -0.30
Diluted Earnings Per Share
15.38%
-0.30
-0.26 -0.31 -0.44 -0.30
$11.27
price down icon 6.16%
WVE WVE
$3.13
price down icon 1.88%
$5.53
price down icon 3.66%
$9.94
price down icon 3.21%
$8.19
price down icon 8.08%
$13.73
price down icon 7.10%
Kapitalisierung:     |  Volumen (24h):